nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—Fluspirilene—ADRA2A—attention deficit hyperactivity disorder	0.0603	0.203	CrCbGaD
Ezetimibe—Pimozide—DRD3—attention deficit hyperactivity disorder	0.0494	0.166	CrCbGaD
Ezetimibe—Fluspirilene—SLC6A4—attention deficit hyperactivity disorder	0.046	0.155	CrCbGaD
Ezetimibe—Fluspirilene—DRD2—attention deficit hyperactivity disorder	0.0457	0.154	CrCbGaD
Ezetimibe—SOAT1—cardiovascular system—attention deficit hyperactivity disorder	0.0411	0.12	CbGeAlD
Ezetimibe—ANPEP—cardiovascular system—attention deficit hyperactivity disorder	0.0393	0.115	CbGeAlD
Ezetimibe—Fluspirilene—HTR2A—attention deficit hyperactivity disorder	0.0353	0.119	CrCbGaD
Ezetimibe—Pimozide—DRD2—attention deficit hyperactivity disorder	0.0342	0.115	CrCbGaD
Ezetimibe—Pimozide—HTR2A—attention deficit hyperactivity disorder	0.0264	0.0889	CrCbGaD
Ezetimibe—SOAT1—nervous system—attention deficit hyperactivity disorder	0.0264	0.0772	CbGeAlD
Ezetimibe—SOAT1—central nervous system—attention deficit hyperactivity disorder	0.0254	0.0744	CbGeAlD
Ezetimibe—ANPEP—nervous system—attention deficit hyperactivity disorder	0.0252	0.0739	CbGeAlD
Ezetimibe—SOAT1—cerebellum—attention deficit hyperactivity disorder	0.0248	0.0727	CbGeAlD
Ezetimibe—ANPEP—central nervous system—attention deficit hyperactivity disorder	0.0243	0.0711	CbGeAlD
Ezetimibe—SOAT1—brain—attention deficit hyperactivity disorder	0.0202	0.059	CbGeAlD
Ezetimibe—ANPEP—brain—attention deficit hyperactivity disorder	0.0193	0.0565	CbGeAlD
Ezetimibe—UGT1A3—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0161	0.0445	CbGpPWpGaD
Ezetimibe—UGT2B7—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0136	0.0378	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0136	0.0378	CbGpPWpGaD
Ezetimibe—ABCC3—nervous system—attention deficit hyperactivity disorder	0.0126	0.0368	CbGeAlD
Ezetimibe—ABCC3—central nervous system—attention deficit hyperactivity disorder	0.0121	0.0355	CbGeAlD
Ezetimibe—UGT1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0111	0.0307	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0108	0.0299	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0104	0.0288	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0103	0.0285	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00991	0.0274	CbGpPWpGaD
Ezetimibe—ABCC3—brain—attention deficit hyperactivity disorder	0.00961	0.0281	CbGeAlD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00941	0.0261	CbGpPWpGaD
Ezetimibe—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00891	0.0261	CbGeAlD
Ezetimibe—UGT2B15—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00842	0.0233	CbGpPWpGaD
Ezetimibe—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.0069	0.0202	CbGeAlD
Ezetimibe—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00666	0.0195	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00619	0.0171	CbGpPWpGaD
Ezetimibe—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00563	0.0165	CbGeAlD
Ezetimibe—ABCG2—brain—attention deficit hyperactivity disorder	0.0056	0.0164	CbGeAlD
Ezetimibe—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.0051	0.0149	CbGeAlD
Ezetimibe—UGT2B15—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00493	0.0136	CbGpPWpGaD
Ezetimibe—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00491	0.0144	CbGeAlD
Ezetimibe—UGT2B15—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00489	0.0135	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00472	0.0131	CbGpPWpGaD
Ezetimibe—UGT1A3—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00451	0.0125	CbGpPWpGaD
Ezetimibe—ABCB1—midbrain—attention deficit hyperactivity disorder	0.0044	0.0129	CbGeAlD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00406	0.0112	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00397	0.011	CbGpPWpGaD
Ezetimibe—UGT2B7—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00383	0.0106	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00376	0.0104	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00361	0.01	CbGpPWpGaD
Ezetimibe—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00361	0.0106	CbGeAlD
Ezetimibe—ABCG8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00358	0.0099	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00354	0.0098	CbGpPWpGaD
Ezetimibe—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00348	0.0102	CbGeAlD
Ezetimibe—ABCG5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00344	0.00953	CbGpPWpGaD
Ezetimibe—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.0034	0.00996	CbGeAlD
Ezetimibe—UGT2B7—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00337	0.00935	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00337	0.00935	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00326	0.00902	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00326	0.00902	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00325	0.009	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0032	0.00887	CbGpPWpGaD
Ezetimibe—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00313	0.00868	CbGpPWpGaD
Ezetimibe—UGT1A1—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00312	0.00863	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00301	0.00833	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00301	0.00833	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00298	0.00825	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00277	0.00767	CbGpPWpGaD
Ezetimibe—ABCB1—brain—attention deficit hyperactivity disorder	0.00276	0.00809	CbGeAlD
Ezetimibe—UGT1A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00274	0.00759	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00268	0.00741	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00264	0.00731	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00264	0.00731	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00262	0.00726	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0026	0.00721	CbGpPWpGaD
Ezetimibe—UGT1A3—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0026	0.00721	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00248	0.00686	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00247	0.00684	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00247	0.00684	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00244	0.00677	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00243	0.00673	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00243	0.00672	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00238	0.0066	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00238	0.00658	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00238	0.00658	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00234	0.00647	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00226	0.00625	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00225	0.00622	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00224	0.00621	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00223	0.00617	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00221	0.00613	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0022	0.00608	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00217	0.00602	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00209	0.0058	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00206	0.00571	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00201	0.00558	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00197	0.00546	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00197	0.00546	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00197	0.00545	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00196	0.00543	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00191	0.00529	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.0019	0.00526	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0019	0.00526	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00188	0.0052	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00182	0.00505	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00182	0.00504	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00181	0.00501	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00181	0.00501	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0018	0.00498	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—COMT—attention deficit hyperactivity disorder	0.0015	0.00414	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00149	0.00411	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00144	0.00399	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—COMT—attention deficit hyperactivity disorder	0.00144	0.00399	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00143	0.00396	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00143	0.00395	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00141	0.00391	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00139	0.00385	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00139	0.00385	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00139	0.00384	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00137	0.00379	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00127	0.00352	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00111	0.00308	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00299	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.00293	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00103	0.00286	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000985	0.00273	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000963	0.00267	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000963	0.00267	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000917	0.00254	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000917	0.00254	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000846	0.00234	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—COMT—attention deficit hyperactivity disorder	0.000842	0.00233	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000836	0.00232	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000772	0.00214	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000764	0.00212	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000746	0.00206	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000745	0.00206	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000745	0.00206	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000737	0.00204	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000733	0.00203	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000717	0.00199	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000683	0.00189	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000681	0.00189	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000664	0.00184	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000641	0.00178	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000633	0.00175	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000633	0.00175	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000633	0.00175	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000633	0.00175	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000633	0.00175	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000623	0.00173	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000623	0.00173	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000617	0.00171	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000595	0.00165	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000579	0.0016	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000579	0.0016	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000567	0.00157	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000515	0.00143	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000515	0.00143	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000515	0.00143	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000512	0.00142	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000508	0.00141	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000506	0.0014	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000506	0.0014	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000506	0.0014	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000482	0.00133	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000482	0.00133	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000472	0.00131	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000472	0.00131	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000471	0.0013	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000464	0.00128	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000451	0.00125	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000448	0.00124	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000437	0.00121	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000437	0.00121	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000431	0.00119	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00043	0.00119	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000411	0.00114	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000399	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000392	0.00108	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000384	0.00106	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000384	0.00106	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000381	0.00105	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000381	0.00105	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000377	0.00104	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000369	0.00102	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—EP300—attention deficit hyperactivity disorder	0.000361	0.001	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000359	0.000995	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000359	0.000994	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000349	0.000967	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000342	0.000947	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000332	0.00092	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00033	0.000913	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000312	0.000863	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00031	0.000857	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000286	0.000791	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000284	0.000786	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000275	0.000762	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000265	0.000733	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000263	0.000727	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000236	0.000654	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000236	0.000654	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000232	0.000643	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000216	0.000598	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000211	0.000583	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000194	0.000536	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000189	0.000523	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00018	0.000498	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000165	0.000456	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000165	0.000456	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000403	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000403	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000143	0.000396	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000143	0.000396	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000142	0.000393	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000134	0.00037	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000133	0.000368	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000123	0.000339	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000322	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000113	0.000314	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.000307	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.81e-05	0.000244	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.75e-05	0.000242	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.13e-05	0.00017	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.78e-05	0.000105	CbGpPWpGaD
